INIS
carcinomas
100%
patients
71%
surgery
30%
photodynamic therapy
30%
tomography
30%
risks
19%
tumors
15%
biopsy
14%
mutations
12%
diseases
12%
uracils
12%
failures
10%
bcc lattices
10%
aminolevulinic acid
9%
clinical trials
9%
images
9%
guidelines
8%
netherlands
8%
therapy
7%
comparative evaluations
6%
genes
6%
assessments
6%
genetics
6%
reviews
6%
applications
6%
fluorouracils
5%
data
5%
skin
5%
detection
5%
metastases
5%
Keyphrases
Basal Cell Carcinoma
48%
Superficial Basal Cell Carcinoma
33%
Optical Coherence Tomography
27%
Photodynamic Therapy
26%
Basal Cell Nevus Syndrome
20%
Confidence Interval
20%
Actinic Keratosis
17%
Imiquimod
15%
Surgical Excision
15%
Randomized Controlled Trial
13%
Non-invasive Treatment
12%
Methyl Aminolevulinate
11%
5-fluorouracil (5-FU)
10%
Treatment Failure
10%
Punch Biopsy
10%
Bowen's Disease
10%
Nodular Basal Cell Carcinoma
10%
Tumor
9%
Netherlands
8%
Randomized Clinical Trial
8%
Non-inferiority Randomized Controlled Trial
7%
Multiple Basal Cell Carcinomas
7%
Histological Subtypes
7%
5-aminolevulinic Acid Photodynamic Therapy
7%
Discrete Choice Experiment
7%
Methyl Aminolaevulinate
6%
PTCH1
6%
Imiquimod Cream
6%
Vismodegib
6%
Dermatologic Surgery
6%
Medicine and Dentistry
Basal-Cell Carcinoma
52%
Photochemotherapy
30%
Optical Coherence Tomography
28%
Superficial Basal Cell Carcinoma
25%
Randomized Controlled Trial
22%
Fluorouracil
18%
Imiquimod
17%
Aminolevulinic Acid Methyl Ester
16%
Neoplasm
13%
Actinic Keratosis
13%
Gorlin Syndrome
10%
Punch Biopsy
10%
Nodular Basal Cell Carcinoma
10%
Aminolevulinic Acid
9%
Non Invasive Procedure
9%
Bowen's Disease
7%
Hedgehog Signaling
7%
Randomized Clinical Trial
6%
Recurrent Disease
6%
Biopsy Technique
5%
Vismodegib
5%
Skin Carcinoma
5%
Cosmetics
5%
